SLAMF1/SLAM/CD150[Biotin], His & Avi, Human
SLAMF1/SLAM/CD150[Biotin], His & Avi, Human

The purity of SLAMF1/SLAM/CD150[Biotin], His & Avi, Human is greater than 95% as determined by SEC-HPLC.

SLAMF1/SLAM/CD150[Biotin], His & Avi, Human

SLAMF1/SLAM/CD150[Biotin], His & Avi, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

SLAMF1/SLAM/CD150[Biotin], His & Avi, Human

SLAMF1/CD150 receptor is a founder of signaling lymphocyte activation molecule (SLAM) family of cell-surface receptors. It is widely expressed on cells within hematopoietic system. In hematologic malignancies CD150 cell surface expression is restricted to cutaneous T-cell lymphomas, few types of B-cell non-Hodgkin's lymphoma, near half of cases of chronic lymphocytic leukemia, Hodgkin's lymphoma, and multiple myeloma.
Z04614
¥123,118.00

Ask us a question
Product Introduction
Species Human
Protein Construction
SLAMF1/SLAM/CD150 (Ala21-Pro237)
Accession # Q13291-1		 His Avi
N-term C-term
Conjugate Biotin
Purity > 95% as determined by Bis­Tris PAGE 
Endotoxin Level Less than 1EU per μg by the LAL method.
Expression System HEK293
Theoretical Molecular Weight 27.2 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 50-60 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.

Examples
  • SLAMF1/SLAM/CD150[Biotin], His & Avi, Human
    • SLAMF1/SLAM/CD150[Biotin], His & Avi, Human

    The purity of SLAMF1/SLAM/CD150[Biotin], His & Avi, Human is greater than 95% as determined by SEC-HPLC.

  • SLAMF1/SLAM/CD150[Biotin], His & Avi, Human
    • SLAMF1/SLAM/CD150[Biotin], His & Avi, Human

    SLAMF1/SLAM/CD150[Biotin], His & Avi, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background SLAMF1/CD150 receptor is a founder of signaling lymphocyte activation molecule (SLAM) family of cell-surface receptors. It is widely expressed on cells within hematopoietic system. In hematologic malignancies CD150 cell surface expression is restricted to cutaneous T-cell lymphomas, few types of B-cell non-Hodgkin's lymphoma, near half of cases of chronic lymphocytic leukemia, Hodgkin's lymphoma, and multiple myeloma.
Synonyms CDw150; IPO-3; CD150; SLAMF1; SLAM

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.